cytarabine has been researched along with Vaccinia in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (92.31) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dodding, MP; Martin, MC; Postigo, A; Way, M | 1 |
de Clerq, E; Janiak, M; Kobus, M; Luczak, M; Szmigielski, S | 1 |
Dudgeon, JA; Hanshaw, JB | 1 |
Conliffe, M; Worthington, M | 1 |
Darzynkiewicz, E; De Clercq, E; Shugar, D | 1 |
De Clercq, E; Luczak, M; Shugar, D; Torrence, PF; Waters, JA; Witkop, B | 1 |
Calabresi, P | 1 |
Khwaja, TA; Long, RA; Robins, RK; Sidwell, RW; Simon, LN; Szekeres, GL | 1 |
Allen, LB; Huffman, JH; Long, RA; Robins, RK; Sidwell, RW; Simon, LN | 1 |
Bauer, DJ | 1 |
Allen, LB; Sidwell, RW | 1 |
Kaufmann, HE | 1 |
2 review(s) available for cytarabine and Vaccinia
Article | Year |
---|---|
Prevention, treatment, and antiviral chemotherapy.
Topics: Chickenpox; Cytarabine; Cytomegalovirus Infections; Female; Fetal Diseases; Hepatitis B; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Immunization, Passive; Infant, Newborn; Infant, Newborn, Diseases; Male; Poliomyelitis; Pregnancy; Pregnancy Complications, Infectious; Rubella; Rubella Vaccine; Transfer Factor; Vaccination; Vaccinia; Vidarabine; Virus Diseases | 1978 |
Antiviral chemotherapy: the first decade.
Topics: Acute Disease; Amantadine; Antiviral Agents; Chickenpox; Chronic Disease; Cytarabine; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Influenza, Human; Molluscum Contagiosum; Semicarbazones; Smallpox; Vaccinia; Warts | 1973 |
11 other study(ies) available for cytarabine and Vaccinia
Article | Year |
---|---|
Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection.
Topics: Antimetabolites, Antineoplastic; Apoptosis; bcl-Associated Death Protein; Cytarabine; Epidermal Growth Factor; Gene Expression Regulation, Viral; HeLa Cells; Host-Pathogen Interactions; Humans; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Peptides; Vaccinia; Vaccinia virus; Viral Proteins; Virulence; Virus Replication | 2009 |
Proceedings: Effect of microwaves on virus multiplication in mammalian cells in vivo and in vitro.
Topics: Animals; Cytarabine; Herpesviridae Infections; Mice; Mice, Inbred Strains; Microwaves; Parainfluenza Virus 3, Human; Respirovirus; Vaccinia; Virus Diseases; Virus Replication | 1976 |
Treatment of fatal disseminated vaccinia virus infection in immunosuppressed mice.
Topics: Animals; Antilymphocyte Serum; Cytarabine; Disease Models, Animal; Drug Evaluation, Preclinical; Idoxuridine; Immunosuppression Therapy; Injections, Intraperitoneal; Mice; T-Lymphocytes; Vaccinia; Vidarabine | 1977 |
Antiviral activity of O'-alkylated derivatives of cytosine arabinoside.
Topics: Alkylation; Animals; Antiviral Agents; Cells, Cultured; Cytarabine; Cytopathogenic Effect, Viral; DNA, Viral; Female; Kidney; Mice; Mice, Inbred Strains; Rabbits; Thymidine; Vaccinia; Vaccinia virus; Virus Replication | 1975 |
Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus.
Topics: Animals; Cytarabine; Deoxyuridine; Drug Interactions; Idoxuridine; Mice; Ribavirin; Ribonucleosides; Vaccinia; Vaccinia virus | 1976 |
Clinical studies with systemic administration of antimetabolites of pyrimidine nucleosides in viral infections.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antimetabolites; Cytarabine; Female; Floxuridine; Gangrene; Herpes Zoster; Hodgkin Disease; Humans; Idoxuridine; Infant; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasms; Rhabdomyosarcoma; Smallpox; Vaccination; Vaccinia; Virus Diseases | 1965 |
Antiviral chemotherapy.
Topics: Amantadine; Animals; Antiviral Agents; Cytarabine; Encephalitis; Herpes Labialis; Herpes Simplex; Herpesvirus 3, Human; Humans; Idoxuridine; Indoles; Influenza, Human; Interferons; Keratitis, Dendritic; Rifampin; Thiosemicarbazones; Vaccinia | 1971 |
Synthesis and antitumor and antiviral activities of 1- -D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates.
Topics: Adenoviridae Infections; Animals; Antineoplastic Agents; Antiviral Agents; Arabinose; Carbodiimides; Cyclic AMP; Cytarabine; Cytosine Nucleotides; Eye Diseases; Herpes Simplex; Kidney; Leukemia L1210; Mice; Myxoma; Nucleotides; Phosphoric Diester Hydrolases; Pseudorabies; Pyrimidine Nucleotides; Rabbits; Uracil Nucleotides; Vaccinia | 1972 |
DNA virus inhibitory activity of 1- -D-arabinofuranosylcytosine-3',5'-cyclic phosphate.
Topics: Adenoviridae; Animals; Carcinoma, Squamous Cell; Cells, Cultured; Cyclization; Cytarabine; Cytomegalovirus; Cytosine Nucleotides; DNA Viruses; Herpesviridae; Herpesviridae Infections; Humans; Keratitis, Dendritic; Lethal Dose 50; Male; Mice; Myxoma virus; Nasopharyngeal Neoplasms; Phosphates; Pseudorabies; Rabbits; Vaccinia; Vaccinia virus | 1973 |
Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine.
Topics: Adenine; Animals; Antiviral Agents; Arabinose; Brain; Cytarabine; Fluorine; Herpes Simplex; Idoxuridine; Male; Mice; Nucleosides; Organ Specificity; Thymidine; Vaccinia | 1972 |
In vivo studies with antiviral agents.
Topics: Animals; Bromodeoxyuridine; Cytarabine; Idoxuridine; Keratitis; Keratitis, Dendritic; Rabbits; Thymidine; Vaccinia | 1965 |